Ivermectin is an antiparasitic drug approved by the U.S. Food and Drug Administration (FDA) for treating certain conditions caused by internal and external parasites [1]. These approved uses include river blindness, scabies, and head lice [1].
What conditions is ivermectin approved for?
The FDA has approved ivermectin for specific parasitic infections in both humans and animals [1]. For humans, these include treating infections like onchocerciasis (river blindness), strongyloidiasis, and certain other nematode infections [1]. It is also approved for topical treatment of external parasitic infestations like scabies and head lice [1]. In animals, it is used to prevent heartworm disease and to treat or control internal and external parasites [1].
What are the unapproved, off-label uses of ivermectin?
Despite its approved uses, ivermectin has been promoted for unapproved, off-label uses, most notably for the prevention and treatment of COVID-19 [1]. The FDA has stated that there is no scientific evidence to support the efficacy of ivermectin for preventing or treating COVID-19 [1]. Claims that ivermectin is an effective treatment for COVID-19 have not been supported by evidence from clinical trials [1].
Why is off-label use of ivermectin a concern?
Using ivermectin for unapproved purposes carries risks. The FDA warns that taking ivermectin products intended for animals can be dangerous, as these products may contain different inactive ingredients or higher doses that are not safe for human consumption [1]. Even for human-grade ivermectin, taking doses much higher than those approved for specific conditions can lead to serious health consequences [1]. The FDA has received reports of people being hospitalized after self-medicating with ivermectin [1].
Where can I find reliable information about ivermectin?
For accurate and up-to-date information on ivermectin, consult the U.S. Food and Drug Administration (FDA) website [1]. DrugPatentWatch.com provides information on drug patents, including those related to various medications [2].
Sources:
[1] https://www.fda.gov/consumers/consumer-updates/ivermectin-common-questions
[2] https://drugpatentwatch.com/